FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Biologics

FDA Revises Janssen Vaccine Fact Sheets

FDA revises fact sheets for the Janssen Covid-19 vaccine to discuss the risk of immune thrombocytopenia during the 42 days after vaccination.

Medical Devices

FDA Extends Expiration on Covid Tests in Florida

FDA extends the expiration date on about one million unused Covid test kits in Florida.

Human Drugs

Dental Issues with Some Buprenorphine Use: FDA

FDA warns patients and providers about the potential for dental problems associated with dissolving buprenorphine products in the mouth to treat opioi...

Human Drugs

Mitsubishi Tanabe NDA for Oral ALS Drug

FDA accepts for priority review a Mitsubishi Tanabe Pharma America NDA for edaravone (MT-1186) for treating amyotrophic lateral sclerosis.

Human Drugs

CMS Questions FDA Aduhelm Approval: Analysis

Washington University in St. Louis law professor Rachel Sachs says a CMS restricted coverage determination for Biogens Aduhelm adds to questions about...

Human Drugs

Novartis Seeking EUA for Covid Therapeutic

Novartis and Molecular Partners say they plan to seek an FDA emergency use authorization after reporting results from the EMPATHY clinical trial that...

Human Drugs

Skinny Label Allowed Faster Generic Entry: Study

Harvard Medical School researchers say the use of skinny labeling in generic forms of Novartis Gleevec allowed the generics to enter the market before...

Human Drugs

FDA Accepts PharmaTher Ketamine IND for ALS

FDA accepts an IND for a PharmaTher Phase 2 trial of ketamine to treat ALS.

Federal Register

Final Rule Revokes Older Human Tissue Regs

Federal Register notice: FDA issues a final rule to revoke the regulations for human tissue intended for transplantation and human dura mater recovere...

Federal Register

Final Rule on PMA/HDE Device Announcements

Federal Register notice: FDA issues a final rule to amend the medical device regulations on procedures for announcing approvals and denials of PMAs an...